BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30567721)

  • 1. Fat-fated microglial dysfunction.
    Silvin A; Ginhoux F
    EMBO J; 2019 Jan; 38(2):. PubMed ID: 30567721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single demyelinating attack is enough to limit brain growth in children.
    Hacohen Y; Patel CB; Hintzen R
    Neurology; 2017 May; 88(18):1691-1692. PubMed ID: 28381511
    [No Abstract]   [Full Text] [Related]  

  • 3. Myelocortical multiple sclerosis: a new disease subtype?
    Stys PK
    Lancet Neurol; 2018 Oct; 17(10):832-834. PubMed ID: 30264718
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination.
    Hacohen Y; Ciccarelli O; Hemingway C
    Brain; 2017 May; 140(5):1172-1174. PubMed ID: 29050372
    [No Abstract]   [Full Text] [Related]  

  • 5. Microglial MHC class II is dispensable for experimental autoimmune encephalomyelitis and cuprizone-induced demyelination.
    Wolf Y; Shemer A; Levy-Efrati L; Gross M; Kim JS; Engel A; David E; Chappell-Maor L; Grozovski J; Rotkopf R; Biton I; Eilam-Altstadter R; Jung S
    Eur J Immunol; 2018 Aug; 48(8):1308-1318. PubMed ID: 29697861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pivotal role of nonmuscle myosin II during microglial activation.
    Janßen S; Gudi V; Prajeeth CK; Singh V; Stahl K; Heckers S; Skripuletz T; Pul R; Trebst C; Tsiavaliaris G; Stangel M
    Exp Neurol; 2014 Nov; 261():666-76. PubMed ID: 25150163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?
    Voss EV; Škuljec J; Gudi V; Skripuletz T; Pul R; Trebst C; Stangel M
    Neurobiol Dis; 2012 Jan; 45(1):519-28. PubMed ID: 21971527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREM2 sustains microglial expansion during aging and response to demyelination.
    Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M
    J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yokukansan Reduces Cuprizone-Induced Demyelination in the Corpus Callosum Through Anti-inflammatory Effects on Microglia.
    Nomura T; Bando Y; You H; Tanaka T; Yoshida S
    Neurochem Res; 2017 Dec; 42(12):3525-3536. PubMed ID: 28929408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigation of demyelinating diseases and quantitative determination of myelin lipids.
    EDGAR GW
    Monatsschr Psychiatr Neurol; 1956; 131(5-6):274-309. PubMed ID: 13348535
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system.
    Taupin V; Renno T; Bourbonnière L; Peterson AC; Rodriguez M; Owens T
    Eur J Immunol; 1997 Apr; 27(4):905-13. PubMed ID: 9130643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial cell activation in demyelinating canine distemper lesions.
    Stein VM; Czub M; Schreiner N; Moore PF; Vandevelde M; Zurbriggen A; Tipold A
    J Neuroimmunol; 2004 Aug; 153(1-2):122-31. PubMed ID: 15265670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial recruitment, activation, and proliferation in response to primary demyelination.
    Remington LT; Babcock AA; Zehntner SP; Owens T
    Am J Pathol; 2007 May; 170(5):1713-24. PubMed ID: 17456776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system.
    Skripuletz T; Miller E; Grote L; Gudi V; Pul R; Voss E; Skuljec J; Moharregh-Khiabani D; Trebst C; Stangel M
    Brain Behav Immun; 2011 Nov; 25(8):1592-606. PubMed ID: 21635946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor.
    Shu Y; Long Y; Wang S; Hu W; Zhou J; Xu H; Chen C; Ou Y; Lu Z; Lau AY; Yu X; Kermode AG; Qiu W
    Ann Clin Transl Neurol; 2019 Feb; 6(2):392-396. PubMed ID: 30847372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin Enhances Microglial Phagocytic Capacity.
    Carden TR; Correale J; Pasquini JM; Pérez MJ
    Mol Neurobiol; 2019 Sep; 56(9):6324-6340. PubMed ID: 30758712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome.
    Iwama S; Sugimura Y; Suzuki H; Suzuki H; Murase T; Ozaki N; Nagasaki H; Arima H; Murata Y; Sawada M; Oiso Y
    Glia; 2011 Mar; 59(3):452-62. PubMed ID: 21264951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive microglia in dysmyelination and demyelination.
    Zhang SC; Goetz BD; Carré JL; Duncan ID
    Glia; 2001 Apr; 34(2):101-9. PubMed ID: 11307159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage.
    Liu J; Tian D; Murugan M; Eyo UB; Dreyfus CF; Wang W; Wu LJ
    J Neurochem; 2015 Oct; 135(2):347-56. PubMed ID: 26173779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945.
    Beckmann N; Giorgetti E; Neuhaus A; Zurbruegg S; Accart N; Smith P; Perdoux J; Perrot L; Nash M; Desrayaud S; Wipfli P; Frieauff W; Shimshek DR
    Acta Neuropathol Commun; 2018 Feb; 6(1):9. PubMed ID: 29448957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.